Tivumecirnon (FLX475) is a potent CCR4 antagonist that blocks regulatory T cells that interfere with effective antitumor immune responses and has antitumor activity[1].
[1]. Hilary Plake BECK, et al. Chemokine receptor modulators and uses thereof. WO2018022992.
















